Oxidative stress and cystic fibrosis-related diabetes: a pilot study in children

Thierry Ntimbane1, Preetha Krishnamoorthy, Céline Huot

  • 1Department of Nutrition, University of Montreal, Montreal, Canada.

Insights

Cystic fibrosis (CF) children exhibit increased oxidative stress linked to impaired glucose metabolism. Nutritional recommendations (NR) may help delay cystic fibrosis-related diabetes (CFRD) onset in these patients.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Metabolic Disorders

Background:

  • Cystic fibrosis (CF) is associated with chronic inflammation and heightened oxidative stress.
  • Understanding the interplay between glucose metabolism and oxidative stress in CF is crucial for patient management.

Purpose of the Study:

  • To investigate the relationship between glucose tolerance and markers of oxidative stress in children with cystic fibrosis.
  • To assess the impact of nutritional interventions on glucose metabolism and oxidative stress in CF patients.

Main Methods:

  • Oral glucose tolerance testing was performed on 31 children (10-18 years old).
  • Blood and urine samples were analyzed for oxidative stress markers (glutathione, HNE-P, DHN-MA).
  • Plasma fatty acid profiles were assessed, and patients with impaired glucose tolerance (IGT) were followed after nutritional recommendations (NR).

Main Results:

  • 42% of CF children presented with impaired glucose tolerance (IGT), and 6% had cystic fibrosis-related diabetes (CFRD).
  • Elevated oxidative stress marker HNE-P correlated with poorer glucose tolerance.
  • Nutritional recommendations (NR) led to normalization of glucose tolerance in 67% of IGT patients, while 22% progressed to CFRD.

Conclusions:

  • CF children demonstrate increased oxidative stress that correlates with worsening glucose metabolism.
  • Nutritional interventions show promise in delaying the progression to CFRD in pediatric CF patients.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.